Depression Clinical Trials in San Antonio

Showing 21-40 of 76 trials

Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans

NCT02657317

This is a research study of an interdisciplinary pain management program for U.S. military veterans who served during the post-9/11 combat eras (e.g., Operations Iraqi Freedom \[OIF\], Enduring Freedom \[OEF\], New Dawn \[OND\]) presenting with chronic musculoskeletal pain related to military service with comorbid depression and/or posttraumatic stress disorder \[PTSD\] symptoms and/or mild traumatic brain injury. This study will test the efficacy of an interdisciplinary pain program compared to treatment as usual in the Veterans Health Administration on pain-related disability, opioid medication use, and pain coping.

Chronic PainTraumatic Brain InjuryPosttraumatic Stress Disorder+2 more

The University of Texas Health Science Center at San Antonio103 participantsStarted Apr 2016

San Antonio, Texas, United States

COMPLETEDPHASE2/PHASE3< 1 mile

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

NCT04832425

This is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive disorder (MDD). Participants will be randomized to receive 28 days of either 40 mg PRAX-114 or placebo in a 1:1 ratio.

Major Depressive Disorder

Praxis Precision Medicines216 participantsStarted Mar 2021

Phoenix, Arizona, United States • Garden Grove, California, United States • Lafayette, California, United States +28 more locations

Establishing Efficacy of a Functional-Restoration Based CAM Pain Management Program in Post-9/11 Veterans

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

Depression Trials in Other Cities

Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder

A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)

A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Participants With Major Depressive Disorder

A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder

A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder

Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD)

A Study to Evaluate SAGE-217 in Participants With Severe Postpartum Depression

A Clinical Trial of Intravenous (IV) Ganaxolone in Women With Postpartum Depression

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder

Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder

A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)

Assessing Symptomatic Clinical Episodes in Depression

A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder

Other Conditions in San Antonio